Skip to main content
The BMJ logoLink to The BMJ
. 1995 Sep 30;311(7009):821–822. doi: 10.1136/bmj.311.7009.821

Confusion over use of placebos in clinical trials.

J Collier
PMCID: PMC2550844  PMID: 7580477

Full text

PDF
821

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aspinall R. L., Goodman N. W. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ. 1995 Sep 30;311(7009):844–846. doi: 10.1136/bmj.311.7009.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dollery C. T. A bleak outlook for placebos (and for science) Eur J Clin Pharmacol. 1979 May 21;15(4):219–221. doi: 10.1007/BF00618508. [DOI] [PubMed] [Google Scholar]
  3. Henry D., Hill S. Comparing treatments. BMJ. 1995 May 20;310(6990):1279–1279. doi: 10.1136/bmj.310.6990.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rothman K. J., Michels K. B. The continuing unethical use of placebo controls. N Engl J Med. 1994 Aug 11;331(6):394–398. doi: 10.1056/NEJM199408113310611. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES